Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Emavusertib for Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

    Not recruiting

    1 1
    Investigated drugs:
    France Germany Spain
  • Study of Elritercept for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes (MDS)

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Spain
  • Study on Continued Treatment with Sabatolimab for Adults with High-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Unfit for Chemotherapy

    Not recruiting

    1 1 1
    Investigated diseases:
    Czechia France Germany Greece Italy Spain
  • Study of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Spain
  • Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders

    Not recruiting

    1 1 1
    France
  • Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

    Not recruiting

    1 1
    Investigated diseases:
    Austria Belgium Estonia Finland France Germany +6
  • Study of SAR443579 Infusion for Adults and Children with Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia, HR-MDS, or BPDCN

    Not recruiting

    1 1 1
    France The Netherlands
  • Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Hungary +3
  • Study of ALX148 and Azacitidine for Untreated Higher Risk Myelodysplastic Syndrome Patients

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study of SEL120 Monohydrochloride for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)

    Not recruiting

    1 1
    Investigated diseases:
    France Germany Italy Poland Spain